Harrow HROW
NASDAQ HROW
$42.62 +0.98 (+2.35%)
At close: Aug 20, 2026 · 11:51 AM UTC

Harrow (HROW) Work In Process (2014 - 2026)

Harrow (HROW) posted quarterly Work In Process of $589000.0 for Q1 2026, up 290.07% year-over-year from $151000.0 in Q1 2025, and down 43.15% quarter-over-quarter from $1.0 million in Q4 2025.

Harrow (HROW) Work In Process (2014 - 2026) Analysis & Trends

Harrow's Work In Process history runs 10 years deep, the most recent figure standing at $589000.0 for Q1 2026.

  • In Q1 2026, Work In Process rose 290.07% year-over-year to $589000.0; the TTM figure through Mar 2026 stood at $589000.0 (up 290.07% YoY), while the FY2025 annual figure was $1.0 million, up 20.75% from the prior year.
  • Work In Process for Q1 2026 stood at $589000.0, down from $1.0 million in the prior quarter.
  • The five-year high for Work In Process was $1.0 million in Q4 2025, with the low at $7000.0 in Q2 2022.
  • The 5-year median for Work In Process is $137000.0 (2024), against an average of $300000.0.
  • The sharpest annual moves came in 2022 and 2024: Work In Process sank 58.82% in 2022, then jumped 1488.89% in 2024.
  • Harrow's Work In Process stood at $38000.0 in 2022, then jumped by 42.11% to $54000.0 in 2023, then surged by 1488.89% to $858000.0 in 2024, then gained by 20.75% to $1.0 million in 2025, then plunged by 43.15% to $589000.0 in 2026.
  • Business Quant data shows HROW's Work In Process at $589000.0 in Q1 2026, $1.0 million in Q4 2025, and $842000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.07 Bn 43.10 Bn -
2 Teva Pharmaceutical Industries 43.42 Bn 39.76 Bn 2.15 Bn
3 Zoetis 31.86 Bn 30.18 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.77 Bn 22.98 Bn 5.10 Bn
5 United Therapeutics 22.29 Bn 19.63 Bn 683.80 Mn
6 Viatris 18.78 Bn 17.89 Bn 1.46 Bn
7 Neurocrine Biosciences 15.66 Bn 15.27 Bn 935.80 Mn
8 Elanco Animal Health 11.91 Bn 11.38 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn -
10 Harrow 1.59 Bn 1.51 Bn 50.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 589,000.00
Dec 31, 2025 1.04 Mn
Sep 30, 2025 842,000.00
Jun 30, 2025 793,000.00
Mar 31, 2025 151,000.00
Dec 31, 2024 858,000.00
Sep 30, 2024 176,000.00
Jun 30, 2024 137,000.00
Mar 31, 2024 140,000.00
Dec 31, 2023 54,000.00
Sep 30, 2023 113,000.00
Jun 30, 2023 60,000.00
Mar 31, 2023 36,000.00
Dec 31, 2022 38,000.00
Sep 30, 2022 26,000.00
Jun 30, 2022 7,000.00
Mar 31, 2022 44,000.00
Sep 30, 2021 51,000.00
Jun 30, 2021 17,000.00
Mar 31, 2021 3,000.00